{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:24:17Z","timestamp":1790522657609,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10787-022-01076-x","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T02:04:01Z","timestamp":1664417041000},"page":"2399-2410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Angiotensin type 2 receptor antagonism as a new target to manage gout"],"prefix":"10.1007","volume":"30","author":[{"given":"Thiago Neves","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 L. Lopes","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Mano","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo Mesquita","family":"Luiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Garcia","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veridiana","family":"de Melo Rodrigues \u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Ricardo","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair Pereira","family":"Cunha-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Anthony","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Mattar","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-2570","authenticated-orcid":false,"given":"Cassia Regina","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"1076_CR1","doi-asserted-by":"publisher","first-page":"39721","DOI":"10.1074\/jbc.M105253200","volume":"276","author":"S AbdAlla","year":"2001","unstructured":"AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276:39721\u201339726. https:\/\/doi.org\/10.1074\/jbc.M105253200","journal-title":"J Biol Chem"},{"key":"1076_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/NM.2156","volume":"16","author":"JC Alves-Filho","year":"2010","unstructured":"Alves-Filho JC, Snego F, Souto FO et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708\u2013712. https:\/\/doi.org\/10.1038\/NM.2156","journal-title":"Nat Med"},{"key":"1076_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso N, So A (2010) Mechanisms of inflammation in gout. Arthritis Res Ther 12:1\u20138","journal-title":"Arthritis Res Ther"},{"key":"1076_CR4","doi-asserted-by":"publisher","first-page":"98s","DOI":"10.1016\/S0895-7061(01)02076-3","volume":"14","author":"RM Carey","year":"2001","unstructured":"Carey RM, Jin XH, Siragy HM (2001) Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens 14:98s\u2013102s","journal-title":"Am J Hypertens"},{"key":"1076_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007383","author":"O Caspani","year":"2009","unstructured":"Caspani O, Zurborg S, Labuz D, Heppenstall PA (2009) The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0007383","journal-title":"PLoS ONE"},{"key":"1076_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jpain.2017.10.006","volume":"19","author":"A Chakrabarty","year":"2018","unstructured":"Chakrabarty A, Liao Z, Mu Y, Smith PG (2018) Inflammatory renin-angiotensin system disruption attenuates sensory hyperinnervation and mechanical hypersensitivity in a rat model of provoked vestibulodynia. J Pain 19:264\u2013277. https:\/\/doi.org\/10.1016\/j.jpain.2017.10.006","journal-title":"J Pain"},{"key":"1076_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW et al (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"key":"1076_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.niox.2004.09.003","volume":"11","author":"L Chen","year":"2004","unstructured":"Chen L, Hsieh MS, Ho HC et al (2004) Stimulation of inducible nitric oxide synthase by monosodium urate crystals in macrophages and expression of iNOS in gouty arthritis. Nitric Oxide Biol Chem 11:228\u2013236. https:\/\/doi.org\/10.1016\/j.niox.2004.09.003","journal-title":"Nitric Oxide Biol Chem"},{"key":"1076_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8190","author":"HK Choi","year":"2012","unstructured":"Choi HK, Soriano LC, Zhang Y, Garci\u00e1 Rodri\u01f5uez LA (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ. https:\/\/doi.org\/10.1136\/bmj.d8190","journal-title":"BMJ"},{"key":"1076_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0304-3959(87)90072-8","volume":"28","author":"TJ Coderre","year":"1987","unstructured":"Coderre TJ, Wall PD (1987) Ankle joint urate arthritis (AJUA) in rats: an alternative animal model of arthritis to that produced by Freund\u2019s adjuvant. Pain 28:379\u2013393. https:\/\/doi.org\/10.1016\/0304-3959(87)90072-8","journal-title":"Pain"},{"key":"1076_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1590\/S0100-879X2004000300018","volume":"37","author":"TM Cunha","year":"2004","unstructured":"Cunha TM, Verri WA, Vivancos GG et al (2004) An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37:401\u2013407. https:\/\/doi.org\/10.1590\/S0100-879X2004000300018","journal-title":"Braz J Med Biol Res"},{"key":"1076_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB et al (2019) Gout. Nat Rev Dis Prim 5:69","journal-title":"Nat Rev Dis Prim"},{"key":"1076_CR13","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021) Gout Lancet 397:1843\u20131855. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9","journal-title":"Gout Lancet"},{"key":"1076_CR14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Phipps-Green A, Frampton C et al (2018) Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis 77:1048\u20131052. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212288","journal-title":"Ann Rheum Dis"},{"key":"1076_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bcp.2016.05.011","volume":"112","author":"VTV Dao","year":"2016","unstructured":"Dao VTV, Medini S, Bisha M et al (2016) Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors. Biochem Pharmacol 112:24\u201336. https:\/\/doi.org\/10.1016\/j.bcp.2016.05.011","journal-title":"Biochem Pharmacol"},{"key":"1076_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/S41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 16:380\u2013390. https:\/\/doi.org\/10.1038\/S41584-020-0441-1","journal-title":"Nat Rev Rheumatol"},{"key":"1076_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/BOR.0000000000000143","volume":"27","author":"A Dumusc","year":"2015","unstructured":"Dumusc A, So A (2015) Interleukin-1 as a therapeutic target in gout. Curr Opin Rheumatol 27:156\u2013163","journal-title":"Curr Opin Rheumatol"},{"key":"1076_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.170806","volume":"45","author":"MM Elfishawi","year":"2018","unstructured":"Elfishawi MM, Zleik N, Kvrgic Z et al (2018) The rising incidence of gout and the increasing burden of comorbidities: A population-based study over 20 years. J Rheumatol 45:574\u2013579. https:\/\/doi.org\/10.3899\/jrheum.170806","journal-title":"J Rheumatol"},{"key":"1076_CR19","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1097\/j.pain.0000000000000690","volume":"157","author":"BL Forte","year":"2016","unstructured":"Forte BL, Slosky LM, Zhang H et al (2016) Angiotensin-(1\u20137)\/Mas receptor as an antinociceptive agent in cancer-induced bone pain. Pain 157:2709\u20132721. https:\/\/doi.org\/10.1097\/j.pain.0000000000000690","journal-title":"Pain"},{"key":"1076_CR20","doi-asserted-by":"publisher","unstructured":"Gumanova NG, Deev AD, Klimushina MV et al (2017) Serum nitrate and nitrite are associated with the prevalence of various chronic diseases except cancer. Int Angiol 36:160\u2013166. https:\/\/doi.org\/10.23736\/S0392-9590.16.03674-9","DOI":"10.23736\/S0392-9590.16.03674-9"},{"key":"1076_CR21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.pain.2011.03.025","volume":"152","author":"C Hoffmeister","year":"2011","unstructured":"Hoffmeister C, Trevisan G, Rossato MF et al (2011) Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats. Pain 152:1777\u20131788. https:\/\/doi.org\/10.1016\/j.pain.2011.03.025","journal-title":"Pain"},{"key":"1076_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/hr.2015.18","volume":"38","author":"H Kawahata","year":"2015","unstructured":"Kawahata H, Sotobayashi D, Aoki M et al (2015) Continuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse. Hypertens Res 38:382\u2013393. https:\/\/doi.org\/10.1038\/hr.2015.18","journal-title":"Hypertens Res"},{"key":"1076_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/648537","volume":"2012","author":"Y Kawakami","year":"2012","unstructured":"Kawakami Y, Matsuo K, Murata M et al (2012) Expression of angiotensin II receptor-1 in human articular chondrocytes. Arthritis 2012:1\u20137. https:\/\/doi.org\/10.1155\/2012\/648537","journal-title":"Arthritis"},{"key":"1076_CR24","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","volume":"111","author":"E Kostenis","year":"2005","unstructured":"Kostenis E, Milligan G, Christopoulos A et al (2005) G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111:1806\u20131813. https:\/\/doi.org\/10.1161\/01.CIR.0000160867.23556.7D","journal-title":"Circulation"},{"key":"1076_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ART.24185","volume":"60","author":"WJ Martin","year":"2009","unstructured":"Martin WJ, Walton M, Harper J (2009) Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 60:281\u2013289. https:\/\/doi.org\/10.1002\/ART.24185","journal-title":"Arthritis Rheum"},{"key":"1076_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/niox.2000.0319","volume":"5","author":"KM Miranda","year":"2001","unstructured":"Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide Biol Chem 5:62\u201371. https:\/\/doi.org\/10.1006\/niox.2000.0319","journal-title":"Nitric Oxide Biol Chem"},{"key":"1076_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00281-013-0361-0","volume":"35","author":"I Mitroulis","year":"2013","unstructured":"Mitroulis I, Kambas K, Ritis K (2013) Neutrophils, IL-1\u03b2, and gout: is there a link? Semin Immunopathol 35:501\u2013512","journal-title":"Semin Immunopathol"},{"key":"1076_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/pme.12258","volume":"15","author":"A Muralidharan","year":"2014","unstructured":"Muralidharan A, Wyse BD, Smith MT (2014) Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain. Pain Med (united States) 15:93\u2013110. https:\/\/doi.org\/10.1111\/pme.12258","journal-title":"Pain Med (united States)"},{"key":"1076_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/ejp.512","volume":"18","author":"W Nemoto","year":"2014","unstructured":"Nemoto W, Ogata Y, Nakagawasai O et al (2014) Angiotensin (1\u20137) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice. Eur J Pain (united Kingdom) 18:1471\u20131479. https:\/\/doi.org\/10.1002\/ejp.512","journal-title":"Eur J Pain (united Kingdom)"},{"key":"1076_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pain.2009.11.006","volume":"148","author":"LG Pinto","year":"2010","unstructured":"Pinto LG, Cunha TM, Vieira SM et al (2010) IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 148:247\u2013256. https:\/\/doi.org\/10.1016\/j.pain.2009.11.006","journal-title":"Pain"},{"key":"1076_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0306-3623(97)00021-9","volume":"29","author":"ME Pueyo","year":"1997","unstructured":"Pueyo ME, Michel JB (1997) Angiotensin II receptors in endothelial cells. Gen Pharmacol 29:691\u2013696","journal-title":"Gen Pharmacol"},{"key":"1076_CR32","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(13)62337-5","volume":"383","author":"ASC Rice","year":"2014","unstructured":"Rice ASC, Dworkin RH, McCarthy TD et al (2014) EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 383:1637\u20131647. https:\/\/doi.org\/10.1016\/S0140-6736(13)62337-5","journal-title":"Lancet"},{"key":"1076_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/rheumatology\/kez259","volume":"59","author":"MF Rossato","year":"2020","unstructured":"Rossato MF, Hoffmeister C, Trevisan G et al (2020) Monosodium urate crystal interleukin-1\u03b2 release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation. Rheumatol (united Kingdom) 59:233\u2013242. https:\/\/doi.org\/10.1093\/rheumatology\/kez259","journal-title":"Rheumatol (united Kingdom)"},{"key":"1076_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/14740338.2017.1284199","volume":"16","author":"N Schlesinger","year":"2017","unstructured":"Schlesinger N (2017) The safety of treatment options available for gout. Expert Opin Drug Saf 16:429\u2013436. https:\/\/doi.org\/10.1080\/14740338.2017.1284199","journal-title":"Expert Opin Drug Saf"},{"key":"1076_CR35","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1523\/JNEUROSCI.3542-17.2018","volume":"38","author":"AJ Shepherd","year":"2018","unstructured":"Shepherd AJ, Copits BA, Mickle AD et al (2018a) Angiotensin II triggers peripheral macrophage-to-sensory neuron redox crosstalk to elicit pain. J Neurosci 38:7032\u20137057. https:\/\/doi.org\/10.1523\/JNEUROSCI.3542-17.2018","journal-title":"J Neurosci"},{"key":"1076_CR36","doi-asserted-by":"publisher","first-page":"E8057","DOI":"10.1073\/pnas.1721815115","volume":"115","author":"AJ Shepherd","year":"2018","unstructured":"Shepherd AJ, Mickle AD, Golden JP et al (2018b) Macrophage angiotensin II type 2 receptor triggers neuropathic pain. Proc Natl Acad Sci USA 115:E8057\u2013E8066. https:\/\/doi.org\/10.1073\/pnas.1721815115","journal-title":"Proc Natl Acad Sci USA"},{"key":"1076_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205739","author":"CR Silva","year":"2016","unstructured":"Silva CR, Oliveira SM, Hoffmeister C et al (2016) The role of kinin B1 receptor and the effect of angiotensin I-converting enzyme inhibition on acute gout attacks in rodents. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205739","journal-title":"Ann Rheum Dis"},{"key":"1076_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10163","volume":"474","author":"WC Skarnes","year":"2011","unstructured":"Skarnes WC, Rosen B, West AP et al (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474:337\u2013344. https:\/\/doi.org\/10.1038\/nature10163","journal-title":"Nature"},{"key":"1076_CR39","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/j.pain.0000000000000369","volume":"157","author":"MT Smith","year":"2016","unstructured":"Smith MT, Anand P, Rice ASC (2016) Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies. Pain 157:S33\u2013S41","journal-title":"Pain"},{"key":"1076_CR40","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/pme.12157","volume":"14","author":"MT Smith","year":"2013","unstructured":"Smith MT, Woodruff TM, Wyse BD et al (2013) A small molecule angiotensin II type 2 receptor (AT2R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44\/p42 MAPK activation in the dorsal root ganglia. Pain Med (united States) 14:1557\u20131568. https:\/\/doi.org\/10.1111\/pme.12157","journal-title":"Pain Med (united States)"},{"key":"1076_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F (2017) Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol 13:639\u2013647","journal-title":"Nat Rev Rheumatol"},{"key":"1076_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/acr.22585","volume":"67","author":"WJ Taylor","year":"2015","unstructured":"Taylor WJ, Fransen J, Jansen TL et al (2015) Study for updated gout classification criteria: identification of features to classify gout. Arthritis Care Res 67:1304\u20131315. https:\/\/doi.org\/10.1002\/acr.22585","journal-title":"Arthritis Care Res"},{"key":"1076_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13746-w","author":"R Terenzi","year":"2017","unstructured":"Terenzi R, Manetti M, Rosa I et al (2017) Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-13746-w","journal-title":"Sci Rep"},{"key":"1076_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2014.04.021","volume":"72","author":"G Trevisan","year":"2014","unstructured":"Trevisan G, Hoffmeister C, Rossato MF et al (2014) TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout. Free Radic Biol Med 72:200\u2013209. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.04.021","journal-title":"Free Radic Biol Med"},{"key":"1076_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/J.FOB.2013.07.001","volume":"3","author":"I Tsukamoto","year":"2013","unstructured":"Tsukamoto I, Inoue S, Teramura T et al (2013) Activating types 1 and 2 angiotensin II receptors modulate the hypertrophic differentiation of chondrocytes. FEBS Open Bio 3:279\u2013284. https:\/\/doi.org\/10.1016\/J.FOB.2013.07.001","journal-title":"FEBS Open Bio"},{"key":"1076_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.ENDINU.2021.05.012","volume":"69","author":"RA Vargas Vargas","year":"2022","unstructured":"Vargas Vargas RA, Varela Mill\u00e1n JM, Fajardo Bonilla E (2022) Renin-angiotensin system: Basic and clinical aspects\u2014a general perspective. Endocrinol Diabetes y Nutr 69:52\u201362. https:\/\/doi.org\/10.1016\/J.ENDINU.2021.05.012","journal-title":"Endocrinol Diabetes y Nutr"},{"key":"1076_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cell.2013.06.022","volume":"154","author":"JK White","year":"2013","unstructured":"White JK, Gerdin AK, Karp NA et al (2013) XGenome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 154:452. https:\/\/doi.org\/10.1016\/j.cell.2013.06.022","journal-title":"Cell"},{"key":"1076_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.09.033","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2011.09.033","journal-title":"Am J Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01076-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01076-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01076-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T15:15:41Z","timestamp":1669389341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01076-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01076-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}